Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
Well over 1 million babies have now been screened for severe combined immune deficiency (SCID) since the September 2021 launch of an in-service evaluation (ISE) in NHS services.
Our latest UK NSC member profile focuses on Professor Chris Hyde.
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.
The UK National Screening Committee is recommending the introduction of screening for tyrosinaemia as part of the newborn blood spot screening programme.
The UK National Screening Committee (UK NSC) received a record number of 29 proposals during its 2022 annual call for topics. This is by far the most submissions it has received in a single year since the annual call process started in 2016.
A public dialogue on the implications of whole genome sequencing (WGS) for newborn screening, commissioned by the UK NSC, has won the 2022 Market Research Society (MRS) award for public policy/social research.
Using evidence maps as the first stage in its evidence review process helps the UK NSC focus its more detailed work on topics where there is the most significant new evidence.
Bob Steele talks about becoming chair of the UK National Screening Committee (UK NSC) in 2016.
We have just published the Screening in the UK: making effective decisions 2013 to 2014 report that summarises all the UK National Screening Committee’s (UK NSC’s) screening recommendations during the year.